KAY E GERALD 4
4 · INTEGRATED BIOPHARMA INC · Filed Nov 10, 2022
Insider Transaction Report
Form 4
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Award
Stock Option (right to buy)
2022-11-09+100,000→ 100,000 totalExp: 2027-11-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission.
- [F2]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023.